A common statement in a regulatory audit is “if it isn’t written down, it didn’t happen.” The guidance on data integrity takes that notion a bit further. FDA expects data to be attributable, legible, contemporaneously recorded, original or a true copy, and accurate (ALCOA) (1). FDA expects that data be reliable and accurate, which means companies need to implement meaningful and effective strategies to manage their data integrity risks.
